Femtosecond Cr:forsterite laser diode pumped by a double-clad fiber.

Femtosecond Cr:forsterite laser diode pumped by a double-clad fiber. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Femtosecond Cr:forsterite laser diode pumped by a double-clad fiber. Abstract Text:

X Liu,L Qian,F Wise,Z Zhang,T Itatani,T Sugaya,T Nakagawa,K Torizuka,

We present a compact, all-solid-state femtosecond Cr:forsterite laser. The laser is pumped by diodes through a double-clad fiber. Kerr-lens mode locking is initiated and stabilized by a semiconductor saturable-absorber mirror with a single InGaAs quantum well. This system generates transform-limited 80-fs pulses near 1.3microm . An average power of 68 mW with fluctuation of much less than 1% is obtained with 3.8 W of absorbed pump power. The stability, efficiency, compactness, and potential for scaling to higher power of this system make it an attractive short-pulse source for applications.

Femtosecond Cr:forsterite laser diode pumped by a double-clad fiber. Publishing Authors By Initials

X Liu,L Qian,F Wise,Z Zhang,T Itatani,T Sugaya,T Nakagawa,K Torizuka,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Femtosecond Cr:forsterite laser diode pumped by a double-clad fiber. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Optics letters

VOLUME: 23

Page Numbers: 129-31

Journal Abbreviation:

ISSN: 0146-9592

DAY: 15

MONTH: Jan

YEAR: 1998

Femtosecond Cr:forsterite laser diode pumped by a double-clad fiber. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 7708433

Femtosecond Cr:forsterite laser diode pumped by a double-clad fiber. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Femtosecond Cr:forsterite laser diode pumped by a double-clad fiber. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Femtosecond Cr:forsterite laser diode pumped by a double-clad fiber.

AFFILIATION:

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Opt Lett

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Femtosecond Cr:forsterite laser diode pumped by a double-clad fiber Related Publications

• Axial resolution and the value of interpolating scan in multislice positron computed tomography.
• Carrier-phase control among subharmonic pulses in a femtosecond optical parametric oscillator.
• Combined scintiscans in the diagnosis of thyroid carcinomas.
• Design of bifunctional radiopharmaceutical for the development of 99mTc complexes for myocardial imaging agents.
• Diode-Pumped Cr:forsterite Laser Mode Locked by a Semiconductor Saturable Absorber.
• Direct radiographic magnification with computed radiography.
• Femtosecond Cr:forsterite laser diode pumped by a double-clad fiber.
• Generation of 12-fs pulses from a diode-pumped Kerr-lens mode-locked Cr:LiSAF laser.
• Generation of 28-fs pulses from a mode-locked ytterbium fiber oscillator.
• In the procurement of stable 99mTc labeled protein using bifunctional chelating agent.
• Measurement of the optical phase relation among subharmonic pulses in a femtosecond optical parametric oscillator.
• Radiologic-pathologic correlations of small lung nodules with special reference to peribronchiolar nodules.
• Relative carrier-envelope phase dynamics between passively synchronized Ti:sapphire and Cr:forsterite lasers.
• ST segment in lead aVR in acute inferior myocardial infarction.
• Search for 99mTc labeled DTS bifunctional radiopharmaceutical: role of functional groups in myocardial accumulation.
• Single-shot measurement of a carrier-envelope phase by use of a time-dependent polarization pulse.
• [Assessment of regional myocardial blood flow and energy metabolism]
• [Exercise 13NH3-positron emission computed tomography (PET) versus exercise single photon emission computed tomography (SPECT)]
• [Malignant lymphoma. Diagnostic approach. 2. Diagnostic imaging]
• [Visualization of prostate cancer with 11C-choline positron emission tomography (PET): localization of primary and recurrent prostate cancer]